GP Flashcards

1
Q

Describe the clinical presentation of irritable bowel syndrome

A

For >6 months:
Abdominal pain and/or
Bloating and/or
Change in bowel habit

Abdominal pain relieved by defecation or associated with altered bowel habit
Symptoms worse with eating
Mucus in stool

May also have lethargy, nausea, bladder symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is irritable bowel syndrome managed?

A

Pharmacological:
Pain - antispasmodics e.g. buscopan
Constipation – laxatives (avoid lactulose, causes bloating)
Diarrhoea – loperamide
Second-line – low-dose tricyclics

Psychological interventions – non-responsive after >12 months, CBT

Dietary advice – regular meals, drink lots of water, reduce alcohol/fizzy drink intake, limit processed foods

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Which pathogens most commonly cause cellulitis?

A

Strep pyogenes (group A strep)
Staph aureus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does cellulitis present?

A

Erythema, swelling, pain, discharge
Golden-yellow crust = staph aureus
May have bullae with more severe
Systemically unwell – fever, malaise, nausea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is cellulitis diagnosed?

A

Clinical diagnosis for mild
Swabs for culture and sensitivities to guide antibiotic therapy
Bloods – FBC, CRP, LFTs, U+Es, blood cultures
More severe – imaging to look for underlying osteomyelitis/septic arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is cellulitis classified? What are the implications of the classification in terms of admission?

A

Eron classification
I – no systemic toxicity, no uncontrolled co-morbidities
II – systemically well or systemically well with co-morbidity (e.g. PVD)
III – significant systemic upset or unstable co-morbidity that may interfere with treatment response
IV – sepsis or severe life-threatening infection e.g. necrotising fasciitis

Admit for IV antibiotics if Eron III or IV, severe or rapidly deteriorating, young or old, immunocompromised, lymphoedema, facial or periorbital cellulitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the empirical antibiotic treatment of choice for cellulitis?

A

Oral flucloxacillin
Penicillin allergic – oral clarithromycin, erythromycin (pregnancy) or doxycycline
If suspicion of MRSA – oral/IV vancomycin
If requiring IV – IV flucloxacillin, IV vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List the typical causative organisms of necrotising fasciitis

A

Type 1 (most common) – mixed aerobes and anaerobes
Type 2 – strep pyogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the clinical presentation of necrotising fasciitis

A

Rapidly spreading wound infection causing skin and deeper soft tissue necrosis – crepitus/gas gangrene, bullae, necrosis are late signs
Acute onset
Pain, swelling, erythema at site
Pain ‘out of keeping’ with physical signs
Hypoaesthesia
Systemic upset, signs of haemodynamic upset – fever, tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the assessment and management of necrotising fasciitis

A

ABG – raised lactate +/- metabolic acidosis
Signs of multi-organ dysfunction – renal failure, impaired liver function, raised glucose, coagulopathy
Blood cultures

Management:
A-E assessment
Resuscitation – IV fluids
Broad spectrum empirical IV antibiotics
- Flucloxacillin
- Benzylpenicillin
- Metronidazole
- Clindamycin
- Gentamicin
Urgent surgical debridement – may need later reconstructive surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the gold-standard investigation for varicose veins?

A

Duplex US to assess valve incompetence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

List treatment options for varicose veins

A

Compression stockings – check ABPI for PVD
Venous ulceration – compression bandaging

Surgical management options:
Vein ligation, stripping and avulsion
Foam sclerotherapy
Thermal ablation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the potential complications for treatment of varicose veins?

A

Haemorrhage
Thrombophlebitis – foam/ablation
DVT
Disease recurrence
Nerve damage – saphenous or sural

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is lymphoedema managed?

A

Manual lymphatic drainage
Compression bandages
Exercises to improve drainage
Weight loss if overweight
Good skin care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are anal fissures? How are they classified by duration? What are the risk factors for developing them?

A

Tears of the squamous lining of the distal anal canal
<6 weeks – acute
>6 weeks chronic

Risk factors
Constipation
IBD
STIs e.g. HIV, syphilis, herpes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How do anal fissures present?

A

Painful, bright red, rectal bleeding
90% on posterior midline – if alternative consider underlying pathology e.g. Crohn’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How are anal fissures managed?

A

Acute
Soften stool – high-fibre diet, high fluid intake, bulk-forming laxatives
Lubricants before defection
Topical anaesthetics
Analgesia

Chronic
Continue as with acute
Topical GTN first-line
If ineffective after >8 weeks referral for sphincterotomy or botox injection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are haemorrhoids? What are the risk factors for developing haemorrhoids?

A

Enlarged vascular cushions around the anus – present at 3, 7 and 11 o’clock

Risk factors:
Chronic constipation, straining when defecating
Pregnancy and vaginal birth
Obesity
Raised-intrabdominal pressure – weight-lifting, chronic cough
Low-fibre diet

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the clinical presentation of haemorrhoids and types of haemorrhoids.

A

Lump around anus, particularly when defecating
Painless, bright red bleeding on toilet paper or after opening bowels (not mixed with stool)
Sore/itchy anus

Types:
External – originate below dentate line, more prone to thrombosis
Internal – originate above dentate line

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How are haemorrhoids managed?

A

Soften stool – diet and fluid intake
Topical local treatments – Anusol (astringent to shrink), lidocaine cream (germoloids), steroid-containing creams (short-term only)

Non-surgical treatments:
Rubber band ligation
Injection sclerotherapy
Infra-red coagulation
Bipolar diathermy

Surgical options:
Haemorrhoidal artery ligation
Haemorrhoidectomy – can result in faecal incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How do thrombosed haemorrhoids present? How are they managed?

A

Acutely painful, purple, swollen lump around anus
If present <72 hours can have surgical management – excision
Otherwise – conservative management with stool softeners, analgesia, ice packs, usually resolve within 10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the aetiology of anal cancers

A

Majority squamous cell carcinomas – below dentate line
Other 10% are adenocarcinomas from upper anal epithelial

Main risk factor is HPV, also HIV, age, smoking, Crohn’s, immunosuppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Describe the clinical presentation of anal cancer

A

Pain
Bleeding
Discharge
Pruritus
Palpable mass
Infection/fistula in locally invasive disease
Sphincter involvement – incontinence, tenesmus
On examination – ulceration, wart-like lesions, mass on PR, inguinal lymphadenopathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

How is anal cancer diagnosed?

A

Proctoscopy to visualise
Examination under anaesthetic + biopsy

Staging:
USS-guided FNA of palpable LNs
CT CAP for mets
MRI pelvis for local invasion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
How is anal cancer managed?
Chemo-radiotherapy for all except T1N0 – can use WLE Surgical management for advanced disease if chemoradiotherapy failed: Mostly abdominoperineal resection – left with colostomy
26
Describe the aetiology of ano-rectal abscesses and their classification
Caused by plugging of anal ducts which drain anal glands Organisms – E. coli, bacteroides, enterococcus Classified by position as – perianal, ischioanal, pelvirectal intersphincteric
27
How do ano-rectal abscesses present?
Pain, worse on sitting Pus-like discharge from anus May be systemically unwell – fever On examination – erythematous, fluctuant tender perianal mass which may be discharging pus If deeper may have no external signs but severe tenderness on PR
28
How are ano-rectal abscesses managed?
Antibiotics, analgesia Examination under anaesthesia and incision and drainage – left to heal by secondary intention Intra-operative proctoscopy to check for fistula
29
What is a fistula-in-ano? Describe the aetiology and risk factors.
Abnormal connection between anal canal and perianal skin Typically occurs as a consequence of perianal abscess Risk factors – IBD (Crohn’s), diabetes, trauma to anal region, previous radiotherapy
30
How does a fistula-in-ano present? How is it investigated?
Recurrent perianal abscess Intermittent/continuous discharge – blood, mucus, faeces, pus Can see or feel tract on examination Investigation – MRI to visualise anatomy of tract
31
How are fistulas-in-ano managed?
Fistulotomy (superficial) – laying open tract and allowing to heal by secondary intention Placement of a seton (high tract) – brings together and closes tract, allows for drainage to prevent infection
32
What is Goodsall’s rule?
Can be used to predict trajectory of tract of perianal fistula Opening posterior to transverse anal line – tract will follow curved course to posterior midline Opening anterior to transverse anal line – tract will follow straight radial course to dentate line
33
List causes of adrenal insufficiency
Primary adrenal insufficiency – Addison’s disease, autoimmune Secondary adrenal insufficiency – lack of ACTH from pituitary, causes include pituitary tumour, infection, surgery, radiotherapy, Sheehan’s syndrome (blood loss during childbirth leads to pituitary necrosis) Tertiary adrenal insufficiency – lack of CRH from hypothalamus, usually due to withdrawal of long-term steroids
34
Describe the clinical presentation of adrenal insufficiency and the investigation findings
Lethargy, weakness, anorexia, nausea and vomiting, weight loss Bronze skin pigmentation (Addison’s) Hypotension – postural especially Investigation findings: Hyponatraemia Hyperkalaemia Hypoglycaemia Metabolic acidosis Primary – high ACTH Secondary – low ACTH Addison’s – adrenal autoantibodies (adrenal cortex antibodies, 21-hydroxylase antibodies) Short synacthen test Give synthetic ACTH Measure blood cortisol at baseline, after 30 minutes and after 60 minutes Failure of cortisol to rise (less than double baseline) indicates primary adrenal insufficiency
35
How is adrenal insufficiency managed?
Replacement steroids – hydrocortisone (glucocorticoid replacement), fludrocortisone (mineralocorticoid replacement) Steroid card and emergency ID tag – can’t stop suddenly Hydrocortisone doses doubled during acute illness
36
How does an adrenal crisis present? How is it managed?
Reduced consciousness Hypotension Hypoglycaemia, hyponatraemia, hyperkalaemia Very unwell! Management IV hydrocortisone – must replace first IV fluid resuscitation Correct hypoglycaemia Monitor and correct electrolytes
37
Define postural hypotension
Sustained reduction in systolic of 20mmHg or more and/or diastolic of 10mmHg within 3 minutes of standing
38
List causes of postural hypotension
Neurogenic – autonomic dysfunction e.g. T2DM, Parkinson’s, SCLC, amyloidosis Non-neurogenic – cardiac disease, dehydration/adrenal insufficiency, vasodilation (e.g. fevers), medications (diuretics, alpha-blockers for prostatic hypertrophy, anti-HTN, insulin, levodopa, tricyclics)
39
How is postural hypotension managed?
Non-pharmacological – avoid standing quickly, prolonged standing, hot environments, large meals, compression stockings, counter-manoeuvres Pharmacological Fludrocortisone – expands plasma volume, contraindicates in heart failure, ascites, CKD, can cause severe hypokalaemia Midodrine – short-acting vasopressor Pyridostigmine – acetylcholinesterase inhibitor, vasoconstrictive effect while standing
40
List the most common causes of gastroenteritis
Viral – rotavirus, norovirus, adenovirus Bacterial – E. Coli (watch out for 0157, produces Shiga toxin which causes haemolytic uraemic syndrome, worse with Abx), campylobacter jejuni, Shigella, salmonella, bacillus cereus, staph aureus toxin
41
Describe the typical causes of gastroenteritis by bacterial pathogen
E. coli – faeces, salads, water Campylobacter – raw/uncooked poultry, untreated water, unpasteurised milk Shigella – drinking water, swimming pools, food Salmonella – raw eggs or poultry Bacillus cereus – food not immediately in fridge after cooking, typically rice left out at room temp
42
Describe management of gastroenteritis
If mild and not systemically unwell – fluid intake, rehydration with oral rehydration salt solution, no antibiotics, advice for reducing transmission Avoid work/social settings for at least 48 hours after last episode of diarrhoea/vomiting Antidiarrhoeals e.g. loperamide not indicates Can take stool sample for microscopy, culture, and sensitivities In hospital: Dehydration – IV fluids Antibiotics for patients with risk of complications when causative organism and sensitivities established
43
Describe the pathophysiology and manifestations of diverticular disease
Diverticulum – outpouching of bowel wall, herniation of colonic mucosa through muscular wall of colon, usually in sigmoid colon Usually occur with age, chronic constipation, NSAID use Diverticulosis – presence of diverticula Diverticular disease – symptoms due to diverticula Diverticulitis – acute inflammation of diverticula
44
Describe the clinical presentation of diverticular disease and acute diverticulitis
Diverticular disease – intermittent lower abdominal pain, colicky, relieved by defection Altered bowel habit, flatulence, nausea Rectal bleeding Diverticulitis Acute pain, sharp, in LIF Localised tenderness Rectal bleeding Systemic upset – anorexia, fever Perforation – peritonism/peritonitis
45
How is diverticular disease/diverticulitis diagnosed?
Diverticulitis – CT abdomen/pelvis Signs – thickening of colonic wall, pericolic fat stranding, abscesses, localised air bubbles, free air (DO NOT PERFORM COLONOSCOPY IN SUSPECTED DIVERTICULITIS DUE TO RISK OF PERFORATION) Diverticular disease – flexible sigmoidoscopy
46
How is diverticular disease managed?
Simple analgesia Fluid/fibre intake Laxatives – bulk forming (ispagula husk), avoid stimulants Mild diverticulitis – oral antibiotics If recurrent acute diverticulitis may need resection
47
How is acute diverticulitis managed?
Uncomplicated – oral co-amoxiclav, analgesia, only take clear liquids for 2-3 days Complicated – NBM, IV antibiotics, analgesia, may require emergency surgery (Hartmann’s procedure – sigmoid colectomy with formation of end colostomy, anastomosis possible later)
48
Describe the aetiology and risk factors for colorectal cancer
Risk factors Age Genetics – hereditary non-polyposis colorectal carcinoma (Lynch syndrome), familial adenomatous polyposis Family history Low fibre diet Obesity Smoking Alcohol IBD Aetiology – mostly progression of normal mucosa to colonic adenoma (polyps) to invasive adenocarcinoma Adenomas can be present for 10 years or more before malignant transformation, occurs in 10%
49
Describe the genetic syndromes associated with colorectal cancer
HNPCC (Lynch syndrome) – autosomal dominant 90% develop cancers, usually of proximal colon, poorly differentiated and highly aggressive Most common gene mutations – MSH2 and MLH1 Risk of other cancers – endometrial cancer (2nd most common), ovary, stomach, small intestine etc. FAP – autosomal dominant Formation of hundreds of polyps by age 30-40, inevitably develop cancer Due to mutation in APC gene Prophylactic total colectomy with ileo-anal pouch in early 20s Also risk duodenal tumours Gardner’s syndrome – FAP + osteomas of skull and mandible, retinal pigmentation, thyroid carcinoma, epidermoid cysts
50
Describe the presentation of and referral criteria for colorectal cancer
Red flags – 2ww referral: =>40 with unexplained weight loss and abdominal pain =>50 with unexplained rectal bleeding => 60 with IDA or change in bowel habit Positive occult blood screening test (qFIT) Right-sided – abdominal pain, IDA, palpable mass in RIF, present late Left-sided – rectal bleeding, change in bowel habit, tenesmus, palpable mass in LIF or PR
51
Describe the screening programme for colorectal cancer
50-74 get qFIT test every 2 years – occult faecal blood test If positive get colonoscopy If negative no follow-up required Over 74 can request screening Also used in patients with symptoms which don’t meet 2ww criteria
52
How is colorectal cancer diagnosed?
FBC – microcytic anaemia CEA – tumour marker, not used for diagnosis but to monitor disease progression and screen for recurrence Gold-standard is colonoscopy with biopsy (if frail may use CT colongraphy) Staging investigations CT CAP MRI rectum – rectal cancers Endo-anal US for early rectal cancers
53
Describe the staging of colorectal cancer
TNM mostly used now Also have Duke’s: A – confined to muscularis propria B – extension through muscularis C – involving regional lymph nodes D – distant mets
54
How is colorectal cancer managed?
Surgery curative Radiotherapy and chemotherapy used as adjuvant/neoadjuvant or palliative treatments Surgery – usually regional colectomy with primary anastomosis or stoma formation Right hemicolectomy or extended right hemicolectomy Caecal or ascending colon tumours, extended for transverse Ileocolic, right colic and right branch of middle colic (branches of SMA/V) divided and removed with mesenteries Left hemicolectomy Descending colon tumours Left branch of middle colic (branches of SMA/V), inferior mesenteric vein and left colic vessels (branches of IMA/V) divided and removed with mesenteries Sigmoidcolectomy Sigmoid colon tumours IMA fully dissected out with tumour Anterior resection High rectal tumours, >5cm from anus Leaves rectal sphincter intact if anastomosis performed Often initially defunctioning loop ileostomy, reversed 4-6 months later Abdominoperineal resection Low rectal tumours, <5cm from anus Excision of distal colon, rectum, and anal sphincters, left with permanent colostomy Hartmann’s procedure Used in emergency bowel surgery, such as obstruction or perforation Complete resection of recto-sigmoid colon with formation of end colostomy and closure of rectal stump
55
Presentation of gastric volvulus
Vomiting Epigastric pain Failure to pass NG tube
56
Describe the cause of bowel obstruction
Most common: Small bowel – adhesions, hernia Large bowel – malignancy, diverticular disease, volvulus Others Strictures – secondary to Crohn’s Intussusception – paediatric Gallstone ileus Ingested foreign body Faecal impaction Meckel’s diverticulum – paediatric
57
How do bowel obstructions present?
Abdominal pain and distension – colicky, cramping pain due to peristalsis Vomiting – earlier in proximal, later in distal Absolute constipation – early in distal, later in proximal Dehydration – significant third spacing Focal tenderness Tinkling bowel sounds Tympanic to percussion
58
How is bowel obstruction investigated?
Bloods including G&S Monitor renal function and electrolytes – 3rd spacing VBG – metabolic derangement (dehydration, vomiting) CT scan with contrast – imaging of choice in suspected bowel obstruction AXR sometimes used first line – SBO – dilated bowel (>3cm), central abdominal, valvulae conniventes visible LBO – dilated bowel (>6cm or >9cm at caecum), peripheral, haustral lines visible
59
How is acute bowel obstruction managed?
NBM NG tube Strict fluid balance and IV fluids for resuscitation Surgery – suspicion of intestinal ischaemia or closed loop obstruction, cause requiring surgical correction (strangulated hernia, obstructing tumour), failure to improve with conservative measures Generally laparotomy, may need resection of bowel with defunctioning stoma
60
What are the potential complications of acute bowel obstruction?
Bowel ischaemia Bowel perforation – peritonitis – sepsis Hypovolaemic shock leading to AKI etc.
61
Describe the clinical features and consequences of malabsorption
GI – diarrhoea, weight loss, bloating, abdominal pain, steatorrhoea, flatulence Extra-intestinal – anaemia, osteopaenia, secondary hyperparathyroidism, peripheral neuropathy, amenorrhoea, infertility, impotence, oedema/ascites (protein loss), faltering growth/delayed puberty in children Deficiencies – iron, B12, folic acid, vitamin D, calcium, vitamin K and other coagulation factors (bleeding)
62
What are the most common causes of malabsorption?
Pancreatic dysfunction – chronic pancreatitis, cystic fibrosis, pancreatic cancer, Zollinger-Ellison syndrome Obstructive jaundice Coeliac disease, cow’s milk intolerance Crohn’s/ulcerative colitis Short bowel syndrome Hypo/hyperthyroidism Diabetes mellitus
63
List the major classes of laxatives, describe their mechanism of action and give examples
Osmotic laxatives – increase amount of fluid in bowel to soften stool, e.g. lactulose, movicol Stimulant – stimulate bowel to contract expelling faeces e.g. senna, picosulphate Bulk forming laxatives – help stool to retain water therefore soften stool e.g. ispaghula husk Rectal medications – glycerin suppository (stimulant), phosphate enema (stimulant)
64
List the types of hernias and the epidemiology of each
Direct inguinal – older men, raised intra-abdominal pressure Indirect inguinal – baby boys, congenital Femoral – older women, raised intra-abdominal pressure Umbilical – babies, associated with Afro-Caribbean ethnicity, Down’s syndrome, mucopolysaccharide storage disorders Epigastric – middle-aged men, chronic raised-intra-abdominal pressure Paraumbilical – chronic raised intra-abdominal pressure Obturator – elderly women
65
Define hernia and list terms used to describe the characteristics of hernias
Hernia = protrusion of a viscus into an abnormal space Reducible – contents of hernia can be manipulated back into original position Incarcerated or irreducible – contents of hernia cannot be pushed back to their original position, usually painful Obstructed – contents of hernia are so compressed that bowel lumen is no longer patent, causing obstruction Strangulated – compression of hernia contents by fascial defect prevents blood flow leading to ischaemia, which can lead to infarction and necrosis, present with severe pain
66
Describe the anatomy of inguinal hernias and how direct and indirect can be differentiated
Inguinal hernia = protrusion of abdominopelvic contents through superficial inguinal ring into groin Normal descent of testes in men or round ligament in women through inguinal canal (+ ilioinguinal nerve and genital branch of genitofemoral nerve), enter at deep inguinal ring and exit at superficial inguinal ring Deep ring is just above mid-point of inguinal ligament, superficial is just above and lateral to the pubic tubercle Direct – caused by defect in posterior wall of inguinal canal (in Hesselbach’s triangle) If reduce and put finger over deep inguinal ring, still protrudes (emerging through posterior defect still) Indirect – enters deep ring, passes through inguinal canal and exits superficial ring If reduce and put finger over deep inguinal ring, stays reduced (abdominal contents can’t enter canal)
67
Describe the clinical presentation of an inguinal hernia
Groin lump – superior and medial to pubic tubercle Usually disappears on pressure or when patient lies down Mainly asymptomatic, may have groin pain/discomfort with activity, rarely becomes strangulated
68
How are inguinal hernias managed?
If symptomatic – surgical repair Options for surgical repair: Open repair – most commonly Lichtenstein technique, preferred for large hernias Laparoscopy repair – total extra-peritoneal or transabdominal pre-peritoneal, quicker recovery and less complications, better for recurrent or bilateral Risk of strangulation about 2% per year, if asymptomatic can discuss need for surgical intervention in future, risk of strangulation and symptoms to look out for
69
What are the major complications of hernias?
Incarceration Strangulation – bowel ischaemia and necrosis Obstruction
70
Describe the anatomy and presentation of femoral hernias
Abdominal viscera pass into femoral canal via the femoral ring Groin lump – inferior and lateral to pubic tubercle Usually quite small Typically non-reducible (small size of femoral ring)
71
How are femoral hernias managed?
All femoral hernias need surgical repair, ideally within 2 weeks, due to high risk of strangulation Two surgical approaches: Low approach – incision below inguinal ligament High approach – incision above inguinal ligament, preferred for emergency as can easily access compromised bowel
72
Describe the clinical presentation of obturator hernias and how they are managed
>90% present as emergency with obstruction/strangulation Deep position so often not a lump on examination Often have pain/paraesthesia in inner thigh due to compression of obturator nerve by hernia, worse with internal rotation of hip and better with hip flexion (Howship-Romberg sign) Management – usually emergency surgery to relieve obstruction and resect compromised bowel
73
Describe the anatomy and presentation of a Richter’s hernia
Partial herniation of bowel involving only one edge – usually anti-mesenteric border Presents with pain from strangulation without features of obstruction, can then develop peritonitis with bowel perforation
74
Describe the differential diagnosis for abdominal masses by location
Epigastric: AAA Gastric cancer Pancreatic pseudocyst or tumour Pyloric stenosis – babies Transverse colon cancer Left lobe of liver Right hypochondrium: Hepatomegaly Enlarged gallbladder – empyema, CBD obstruction Kidney mass Colon cancer Left hypochondrium: Splenomegaly Kidney mass Pancreatic cancer Colon cancer Right iliac fossa: Colon cancer Ovarian cyst/tumour Appendiceal abscess Psoas abscess Lymphadenopathy Crohn’s disease Ileocaecal TB Transplanted kidney Left iliac fossa: Colon cancer Faeces – loaded sigmoid, constipation Diverticular disease Ovarian tumour or cyst Psoas abscess Crohn’s Transplanted kidney Lymphadenopathy Suprapubic: Endometrial cancer Bladder cancer Enlarged bladder – retention Fibroids Pregnancy Ovarian mass e.g. cyst Inguinal: Herniae – inguinal, femoral Lymphadenopathy Vascular – saphena varix, aneurysm, pseudoaneurysm Psoas abscess Ectopic/undescended testes Hydrocoele of spermatic cord
75
Describe the differential diagnosis for generalised and localised abdominal pain
Generalised: Peritonism – perforated peptic ulcer, bowel, AAA, ectopic pregnancy Early appendicitis Pancreatitis Ischaemic bowel Central/peri-umbilical: Small bowel ischaemia Acute appendicitis Small bowel obstruction Pancreatitis Testicular torsion Medical e.g. DKA Epigastric: Pancreatitis Gastritis Peptic ulcer Cancer – gastric, pancreatis Boerhaave syndrome IBS Pulmonary – pneumonia, pleurisy Cardiac – MI, pericarditis Left hypochondrium: Pancreatitis Ruptured spleen Acute pyelonephritis Right hypochondrium: Biliary colic Acute cholangitis Cholecystitis Hepatitis Hepatomegaly Fitz-Hugh-Curtis syndrome Perforated duodenal ulcer Acute pyelonephritis RIF: Appendicitis Crohn’s Meckel’s diverticulum Colon cancer IBS Ectopic pregnancy Acute ovarian event – torsion, rupture, haemorrhage PID Endometriosis Renal colic UTI Hip pathology LIF: Diverticulitis Colitis Colon cancer Constipation IBS Ectopic pregnancy Acute ovarian event PID Endometriosis Renal colic UTI Hip pathology Suprapubic: Urinary retention Cystitis Uterine – PID, fibroid, menstruation Groin: Renal calculi Scrotal – testicular torsion, Epididymo-orchitis Inguinal hernia Hip pathology
76
Describe the differential diagnosis for abdominal distension
Fat – obesity Flatus – intestinal obstruction Fetus – pregnancy Fluid – ascites, distended bladder Faeces – constipation, faecal impaction Tumour Organomegaly
77
Describe the presentation, investigation, and management of breast cysts
Benign, fluid-filled lumps Very common in women 30-50, especially perimenopausal Can cause pain, often cyclical related to menses On examination feel smooth, well-circumscribed, fluctuant, mobile lump Investigation – aspiration If blood-stained fluid or persistently refill should be excised, otherwise resolve with aspiration Small increased risk of breast cancer, especially in younger women
78
Describe the presentation and management of fibrocystic breast changes
Most common in middle-aged menstruating women Fluctuating breast size and lumpiness, breast pain/tenderness, typically occur before menstruation and resolve when menstruation begins Improve or resolve after menopause Management: NSAIDs Avoid caffeine Apply heat Hormonal treatments e.g. tamoxifen under specialist guidance
79
Describe the aetiology, presentation, and management of mastitis/breast abscesses
Infection of the mammary ducts causes mastitis, which can lead to formation of breast abscess Often associated with lactation Most common organism is staph aureus Mastitis – purulent nipple discharge, localised pain, warmth, erythema, swelling Breast abscess: Present as painful, immobile, subcutaneous lumps, tethered to skin, with erythema and warmth of skin Tender on palpation May have fever, malaise, signs of sepsis Management: Lactational mastitis – conservative management, continue breastfeeding, breast massage, heat, simple analgesia Antibiotics (flucloxacillin or erythromycin/clarithromycin) if symptoms don’t improve Breast abscess – antibiotics, drainage (aspiration or incision and drainage), send fluid for C+S
80
Describe the aetiology and presentation of breast fibroadenomas
Benign tumours of stromal/epithelial breast tissue More common in women 20-40, respond to oestrogen and progesterone so usually regress after menopause Presentation: Firm, smooth, mobile Painless Well-circumscribed Up to 3cm diameter
81
How are fibroadenomas managed? Describe their prognosis.
Generally – 1/3 regress, 1/3 enlarge, 1/3 stay same size If diagnostic uncertainty – US +/- FNA Management – observation and reassurance Can excise if large
82
Describe the aetiology, presentation, diagnosis and management of traumatic fat necrosis of the breast
Occurs after traumatic injury to breast tissue, leads to fibrosis and calcification Presents as immobile, firm lump at area of injury, may be bruising Diagnosis – triple assessment – US/mammogram, FNA Management – exclude breast cancer, treat conservatively or surgically excise if required
83
Describe the differential diagnosis for breast pain
Cyclical – related to menstruation, typically during 2 weeks before menstruation with other premenstrual symptoms Breast cancer Infection – mastitis or breast abscess Pregnancy Trauma Extra-mammary causes – MSK conditions (e.g. costochondritis), soft tissue injury, rib fracture Referred pain from cardiac (IHD) or GI (reflux, peptic ulcer) conditions
84
Describe the aetiology, presentation, diagnosis, and management of mammary duct ectasia
Usually in perimenopausal women, smoking is major risk factor Terminal mammary ducts become dilated, shortened and inflamed Presentation – nipple discharge (creamy, green, brown, bloody), tenderness, nipple retraction/inversion, lump below/around areolar complex Can be confirmed with US Usually no treatment required, smoking cessation advice, can have surgical excision of the duct (microdochectomy) if older and problematic
85
Describe the aetiology, presentation, investigation and management of duct papillomas
Warty lesion, proliferation of epithelial cells in ducts Benign Mostly occur between 35-55 Presentation: Often asymptomatic, picked up incidentally Nipple discharge – clear or blood-stained Tenderness/pain Palpable lump Diagnosis – triple assessment, ductography (inject contrast into duct and perform mammogram) Management – complete surgical excision, histology examination after to check for abnormalities missed on biopsy
86
What is the differential diagnosis for galactorrhoea? How is galactorrhoea diagnosed and managed?
Hyperprolactinaemia: Idiopathic Prolactinomas – prolactin-secreting pituitary adenomas Endocrine disorders – hypothyroidism, PCOS Medications – dopamine antagonists Diagnosis: Pregnancy test for all women of childbearing age Serum prolactin TFTs MRI to diagnose pituitary tumours Management: Dependent on underlying cause Dopamine agonists e.g. bromocriptine or cabergoline Prolactinoma – trans-sphenoidal removal of tumour
87
Describe the causes of gynaecomastia
Idiopathic Hyperprolactinaemia – prolactinoma, dopamine antagonists Physiological in adolescents High oestrogen – obesity, testicular cancer (Leydig cell tumour), liver cirrhosis/failure, hyperthyroidism, hCG secreting tumour (SCLC) Low testosterone – hypothalamus/pituitary conditions, Klinefelter’s, orchitis, testicular trauma/torsion Medications – anabolic steroids, dopamine antagonists, digoxin, spironolactone, GnRH agonists, opiates, alcohol
88
Describe the histological types and epidemiology of breast cancer and pre-cancerous conditions
Invasive ductal carcinoma and ductal carcinoma in-situ: Most common Four subtypes of DCIS – papillary, cribiform, solid and comedo, mostly mixed Invasive lobular carcinoma and lobular carcinoma in-situ: LCIS predominantly in pre-menopausal women, most commonly bilateral compared to DCIS Invasive lobular more common in older women, more difficult to detect Others (rarer): Medullary breast cancer Mucinous (mucoid or colloid) breast cancer Metaplastic breast cancer Lymphoma of the breast Inflammatory breast cancer Phyllodes tumour 50% benign, 25% borderline, 25% malignant
89
List the risk factors for breast cancer
Female sex Increasing age – risk doubles every 10 years until menopause Family history Genetic – 10%, BRCA1/2 Exposure to unopposed oestrogen – early menarche, late menopause, nulliparity, long-term use of HRT, OCP Previous benign breast disease, obesity, alcohol consumption, smoking Breastfeeding is protective
90
Describe the investigation, management and prognosis of breast carcinoma in situ
DCIS often detected during screening due to presence of microcalcifications, confirmed with biopsy LCIS does not have microcalcifications, difficult to detect on imaging, usually only picked up incidentally on biopsy Prognosis DCIS – 2x risk of invasive breast cancer LCIS – greater risk of malignant transformation (7-12x increased risk of invasive breast cancer) Any DCIS should be surgically excised – breast-conserving with WLE or mastectomy if widespread/multifocal LCIS management dependent on extent of disease – low-grade usually monitored, if have BRCA1/2 may need bilateral prophylactic mastectomy
91
Describe the clinical presentation of invasive breast cancer
Often asymptomatic, picked up on screening Breast or axillary lump – hard, irregular, ill-defined, tethered or fixed Asymmetry or swelling Abnormal nipple discharge – unilateral, bloody Nipple retraction Skin changes – dimpling, peau d’orange, Paget’s) Mastalgia (rarely) Late signs associated with metastases – weight loss, bone pain, fatigue
92
Criteria for 2ww referral for breast cancer
=>30 with unexplained breast lump with or without pain =>50 with unilateral nipple discharge, retraction Consider for skin changes suggestive of breast cancer or => with unexplained lump in axilla
93
How are breast lumps assessed?
Triple assessment – History and examination by breast surgeon Radiological imaging Core biopsy or FNA Imaging – US for younger women (<40), mammogram for older Biopsy – FNA for smaller cystic lumps, core biopsy better for diagnosis
94
Describe screening for breast cancer
Women 50-70 every 3 years, mammogram Increased risk – screening from younger age First degree female relative diagnosed with breast cancer <40 First degree male relative diagnosed with breast cancer at any age First degree relative with bilateral breast cancer, primary diagnosed <50 Two first degree relatives, or one first-degree and one second-degree diagnosed with breast cancer at any age One first-degree or one-second degree with breast cancer at any age AND one first-degree or second-degree diagnosed with ovarian cancer at any age Three first-degree or second-degree relatives diagnosed with breast cancer at any age
95
Describe the investigation of breast cancer
Initially triple assessment – examination, imaging (US/mammogram), FNA/core biopsy MRI assess size/features of tumour LN assessment – US then biopsy of abnormal nodes Sentinel LN biopsy during surgery – isotope contrast and blue die injected into tumour area, first node which goes blue/shows up on scan gets biopsied to look for spread Test for receptors – ER, PR and HER2 Gene profiling – gives probability of recurrence as distant metastasis, guides treatment Staging – CT CAP, isotope bone scan
96
List the options for management of breast cancer and describe when each may be appropriate
Surgery – most offered surgery unless old and frail with metastatic disease Breast-conserving (wide local excision) or mastectomy depending on extent of tumour Axillary clearance if nodal disease Offered breast reconstruction to give cosmetically suitable result – immediate or delayed, implant or flap Radiotherapy – in breast-conserving surgery to reduce recurrence Chemotherapy – neoadjuvant (shrink before surgery), adjuvant (reduce recurrence after surgery) or treatment (metastatic or recurrent) Hormone treatment – for oestrogen-receptor positive Premenopausal – tamoxifen Postmenopausal – aromatase inhibitors (letrozole, anastrozole) Other options – fulvestrant (selective oestrogen receptor downregulator), GnRH agonists (goserelin), ovarian surgery (usually in BRCA1/2 mutations) Targeted treatment: Trastuzumab (Herceptin) or pertuzumab – HER2 positive
97
What are the potential complications of breast cancer and treatment of cancer?
Metastases: Liver Lung Bone Brain Surgery – lymphoedema Radiotherapy – local skin and tissue irritation/swelling, fibrosis and shrinking of breast tissue, skin colour changes Tamoxifen – prevents osteoporosis but increases risk of endometrial cancer, VTE Trastuzumab (Herceptin) – heart failure, arrhythmia, hypertension
98
Describe the mechanism of action of hormonal therapies used in breast cancer
Tamoxifen – selective oestrogen receptor modulator, acts to block oestrogen receptors in breast but stimulate those in uterus and bones Aromatase inhibitors – inhibits aromatase which converts androgens to oestrogens, decreasing oestrogen production
99
Describe the diagnosis of asthma
First-line investigations: Spirometry – restrictive picture FEV1 and FVC reduced, FEV1:FVC <70% Bronchodilator reversibility - >12% and 200ml or 400ml increase in FEV1 ?Bronchial challenge with histamine/methacholine FeNO testing (fractional exhaled nitric oxide) Adults >= 40 ppb positive Children >= 35 ppb positive If diagnosis uncertain: PEFR testing – asthma diary, 2-4 weeks, look for diurnal variation (>20% variability) Skin prick testing for allergy Bloods – eosinophil count, total IgE
100
Describe the management of asthma in adults
General: Avoid triggers – allergens Smoking cessation Influenza and pneumococcal vaccination Personalised asthma action plan Step 1 – SABA (salbutamol) Step 2 – add low dose ICS Step 3 – add trial leukotriene receptor antagonist (montelukast) Step 4 – add LABA (salmeterol), continue LTRA depending on dose Step 5 – switch ICS/LABA for MART that includes low-dose ICS Step 6 – moderate dose ICS MART, or switch to separate moderate dose ICS and LABA Step 7 – increase ICS to high-dose (not part of MART) or add additional drug (LAMA, theophylline) +/- specialist referral
101
Describe the aetiology and presentation of COPD
Smoking – main risk factor Occupational exposure Air pollution Alpha-1 anti-trypsin deficiency Shortness of breath – exertional and progresses to rest Wheeze Productive cough Recurrent LRTIs Headache – CO2 retention Pursed lip breathing Peripheral cyanosis Finger clubbing Barrel chest CO2 retention flap Cor pulmonale – signs of right heart failure, peripheral oedema, hepatomegaly
102
How is COPD diagnosed and the severity categorised?
Spirometry – FEV1/FVC <70% Little response to bronchodilators Severity based on FEV1 Stage 1 – FEV1 >80% predicted Stage 2 – FEV1 50-79% predicted Stage 3 – FEV1 30-49% predicted Stage 4 FEV1 <30% predicted Other investigations: CXR – rule out cancer, hyperinflation, flattened diaphragm FBC – polycythaemia (response to chronic hypoxia) Sputum culture for chronic infections e.g. pseudomonas Serum alpha-1 antitrypsin
103
Describe the long-term management of COPD
General: Smoking cessation Influenza and pneumococcal vaccination Step 1 – SABA or SAMA Step 2 – no asthmatic features give LABA and LAMA, asthmatic features give LABA and ICS Step 3 – triple therapy with LABA, LAMA and ICS In more severe cases can use nebulisers (salbutamol and/or ipratropium), oral theophylline, oral mucolytics (carbocysteine), long-term prophylactic antibiotics (azithromycin), long-term home oxygen therapy Long term oxygen therapy indications: pO2 <7.3 or pO2 7.3-8 and secondary polycythaemia, peripheral oedema or pulmonary hypertension (Can’t give to current smokers!!)
104
Describe the aetiology and clinical presentation of acute exacerbations of COPD
Most common organisms – Haemophilus influenzae Strep pneumoniae Moraxella catarrhalis Presentation Increased sputum production Purulent sputum Increased dyspnoea, cough, wheeze Type 2 respiratory failure – raised CO2 with low O2
105
How are acute exacerbations of COPD managed?
Oxygen therapy – maintain sats 88-92% Nebulisers – salbutamol (SABA) and ipratropium (SAMA) Oral steroids (IV if severe) Antibiotics if symptoms suggestive of an infective cause – fever, purulent sputum, focal creps Oral doxycycline, oral amoxicillin or oral clarithromycin If severe – IV aminophylline, NIV (BiPaP), intubation and ventilation
106
Describe the clinical presentation and diagnosis of idiopathic pulmonary fibrosis
Men 50-70 Progressive exertional dyspnoea Bibasal fine end-inspiratory creps Dry cough Clubbing Spirometry – restrictive picture (FEV1 normal/decreased, FVC decrease, FEV1/FVC increased) CT is investigation of choice for diagnosis – ground glass opacities peripherally which progress to honeycombing
107
Describe the causes of pulmonary fibrosis
Upper zone Hypersensitivity pneumonitis (extrinsic allergic alveolitis) Coal worker’s pneumoconiosis Silicosis Sarcoidosis Ankylosing spondylitis TB Radiation-induced pulmonary fibrosis – radiation for breast/lung cancer Lower zone (more common) Idiopathic pulmonary fibrosis Connective tissue disorders e.g. SLE Drug-induced – amiodarone, bleomycin, methotrexate Asbestosis
108
Describe the causes of bronchiectasis
Post-infectious – most common: Recurrent childhood LRTIs TB Pulmonary disease: COPD Asthma Congenital: CF Primary ciliary dyskinesia Alpha-1 antitrypsin deficiency Connective tissue disease: RA SLE Sarcoidosis
109
Describe the clinical presentation of bronchiectasis
Chronic cough with large volume sputum production Haemoptysis Dyspnoea Course creps Rhonchi High-pitched inspiratory squeaks and pops
110
How is bronchiectasis managed?
Chest physio Smoking cessation Mucolytics Antibiotics for infections (most commonly haemophilus, pseudomonas, klebsiella, strep pneumoniae), potentially long-term prophylactic antibiotics Bronchodilators for severe Surgery – resection or transplant
111
Describe the clinical presentation of tuberculosis infection
Often asymptomatic Fever, lethargy, anorexia, weight loss, night sweats, lymphadenopathy Pulmonary – cough, purulent sputum or haemoptysis, dyspnoea, pleuritic chest pain Symptoms of extra-pulmonary disease – urinary symptoms, back pain, headache, chest pain, abdominal pain/bloating
112
How is tuberculosis diagnosed?
To diagnose latent TB – Mantoux test – inject tuberculin and measure skin response, can be falsely negative in immunosuppressed/young Interferon-gamma release assay – used where Mantoux may be falsely negative or to confirm after Mantoux is positive If positive, to diagnose active TB – CXR – signs suggestive of pulmonary TB, upper lobe consolidation/cavitation/granuloma formation, hilar lymphadenopathy Sputum sample for Ziehl-Nielsen staining for acid-fast bacilli, culture and sensitivities (drug-resistance is common) Sputum culture is gold standard but can take weeks NAAT – allows rapid diagnosis, less sensitive than culture
113
Describe treatment of tuberculosis
Active 2 months of: Ethambutol Pyrazinamide Rifampicin Isoniazid Another 4 months of: Rifampicin Isoniazid Latent: 6 months of isoniazid only OR 3 months of rifampicin and isoniazid
114
Describe the mechanism of action and side effects of drugs used for management of tuberculosis
Rifampicin – inhibits bacterial DNA dependent RNA polymerase preventing transcription of DNA to mRNA Potent liver enzyme inducer Hepatitis Orange secretions Flu-like symptoms Isoniazid – inhibits mycolic acid synthesis Peripheral neuropathy – must be given with pyridoxine (Vit B6) Hepatitis Agranulocytosis Live enzyme inhibitor Pyrazinamide – inhibits fatty acid synthase Hyperuricaemia causing gout Arthralgia, myalgia Hepatitis Ethambutol – inhibits arabinosyl transferase which polymerises arabinose to arabinan Optic neuritis – check visual acuity before and during treatment Adjust dose in renal impairment
115
Describe the aetiology and clinical presentation of pneumonia
Most common organisms – Viral – rhinovirus, adenovirus, coronavirus Bacterial - strep pneumoniae, staph aureus, haemophilus, atypical (myoplasma), pneumococcal, klebsiella (alcoholics) Fungal – pneumocystis jiroveci Presentation Cough with purulent sputum Dyspnoea Pleuritic chest pain Fever Malaise Signs of infection – temp, tachycardia, hypotension, confusion, low sats, creps, bronchial breathing, dullness to percussion
116
How is hospital acquired pneumonia defined?
Develops >48 hours since admission
117
How is pneumonia assessed?
CRB-65 (community) Confusion – AMT <8/10 Respiratory rate >30 Blood pressure – SBP <=90 and/or diastolic <=60 Age >65 Hospital assessment if score more than 0, especially if score 2 or more CURB-65 (hospital) Confusion Urea >=7 Respiratory rate >30 Blood pressure – SBP <=90 and/or diastolic <=60 Age >65 Home care if 0 or 1, hospital admission for 2 or more, consider ICU for 3 or more Investigations CXR – consolidation Bloods – FBC, U+Es, CRP, blood cultures Sputum sample Legionella antibodies if at risk (recent holiday, infected water exposure)
118
List atypical causes of pneumonia and their defining features
Legionella – exposure to infected water/air conditioning, causes hyponatraemia which leads to SIADH Mycoplasma – erythema multiforme rash (target lesions), neurological symptoms in young patients Chlamydophila – school aged children with mild-moderate chronic pneumonia Coxiella burnetti (Q fever) – exposure to animals and bodily fluids (typically farmer) Chlamydia psittaci – contact with infected birds (typically farmer)
119
How is pneumonia managed?
Oxygen – sats 94-98% unless risk of type 2 respiratory failure, then 88-92% IV fluids Analgesia for pleuritic pain DVT prophylaxis Low-severity CAP – amoxicillin, 5 days Moderate and high-severity (CURB-65 >3) – IV clarithromycin + IV amoxicillin (or co-amoxiclav if in HDU/ICU) All need CXR in 6 weeks to check for resolution
120
List causes of anaemia
Microcytic – TAILS Thalassaemia Anaemia of chronic disease (more commonly normocytic) Iron deficiency anaemia Lead poisoning Sideroblastic anaemia Normocytic – 3As, 2Hs Acute blood loss Anaemia of chronic disease – including CKD Aplastic anaemia Haemolytic anaemia Hypothyroidism Macrocytic: Megaloblastic Vitamin B12 deficiency Folate deficiency Normoblastic Alcohol Reticulocytosis (haemolytic anaemia or blood loss) Drugs e.g. azathioprine, methotrexate Liver disease Hypothyroidism Pregnancy Myelodysplasia
121
Describe the presentation of anaemia
Dyspnoea Tiredness Headaches Dizziness Pallor Tachycardia Koilonychia Angular chelitis Atrophic glossitis Brittle hair and nails
122
How is iron deficiency anaemia managed?
Address underlying cause e.g. menorrhagia, dietary deficiency Oral iron first-line (ferrous sulfate, ferrous fumarate) for 3 months Consider IV iron if oral contraindicated, ineffective or not tolerated – check compliance and manage side effects (e.g. constipation, take after meals, reduce dose frequency)
123
List causes of thrombocytopaenia
Problems with platelet production: Sepsis B12 or folic acid deficiency Liver failure – reduced thrombopoietin production Leukaemia Myelodysplastic syndrome Problems with destruction: Medications – sodium valproate, methotrexate, isotretinoin, antihistamines, PPIs Alcohol ITP Heparin-induced thrombocytopaenia Haemolytic uraemic syndrome
124
Describe the pathophysiology and consequences of heparin-induced thrombocytopaenia
Development of antibodies against platelets in response to exposure to heparin – against platelet factor 4 Activate clotting mechanisms and destroy platelets so have thrombocytopaenia and clots
125
List causes of haemolytic anaemia
Hereditary Membrane – hereditary spherocytosis/elliptocytosis Metabolism – G6PD deficiency Haemoglobinopathies – sickle cell, thalassaemia Acquired Immune (Coombs-positive) Autoimmune – warm/cold antibody type Alloimmune – transfusion reaction, haemolytic disease of the newborn Drugs – methyldopa, penicillin Non-immune (Coombs-negative) Microangiopathic haemolytic anaemia – TTP, HUS, DIC, malignancy, pre-eclampsia Prosthetic heart valves Paroxysmal nocturnal haemoglobinuria Malaria Dapsone Zieve syndrome
126
Describe the clinical consequences of thalassaemias
Alpha-thalassaemia 1 or 2 alleles abnormal – hypochromic, microcytic but typically normal Hb 3 abnormal – HbH disease, hypochromic, microcytic anaemia with splenomegaly 4 abnormal – death in utero due to hydrops fetalis Beta-thalassaemia Minor – hypochromic, microcytic anaemia Major – failure to thrive, hepatosplenomegaly, microcytic anaemia (requires repeated transfusion which leads to iron overload, so need iron chelation)
127
How does hereditary spherocytosis present? How is it managed?
Presentation – failure to thrive, jaundice, gallstones, splenomegaly, aplastic crisis precipitated by parvovirus infection, spherocytes on blood film Management – Acute haemolytic crisis – supportive management, transfusion if needed Long term – folate replacement, splenectomy (stops spherocytes from being destroyed)
128
Describe the aetiology and presentation of urinary tract infections
Common organisms: E. Coli Klebsiella Enterococcus Risk factors: Women Pregnancy Catheter Sexually active BPH Diabetes Children – vesicoureteral reflux Presentation: Urinary frequency, urgency Incomplete voiding Dysuria Haematuria New incontinence Confusion in elderly Lower abdominal/flank pain Upper – fever and chills, nausea and vomiting, renal angle tenderness
129
How are UTIs managed?
Uncomplicated lower UTI in adult, non-pregnant women: Can try supportive care with analgesia, fluids If prescribing antibiotic – oral nitrofurantoin (eGFR >45) or trimethoprim for 3 days, can give delayed and advise to start if symptoms do not improve within 48 hours or worsen at any time Pregnant, no haematuria, including asymptomatic bacteriuria: Nitrofurantoin (avoid at term), or amoxicillin (if susceptible) or cefalexin for 7 days Catheter-associated UTI (not pregnant), men: Don’t treat catheter-associated asymptomatic bacteriuria Nitrofurantoin, trimethoprim or amoxicillin (if sensitive) for 7 days Upper UTI: Non-severe no sepsis – oral ciprofloxacin or oral trimethoprim, 7 days Urosepsis/pyelonephritis – IV gentamicin, if eGFR <2 oral ciprofloxacin, for 7 days Always send MSSU for culture and sensitivities to guide antibiotic therapy
130
Describe aetiology and presentation of bladder cancer
Risk factors for urothelial (transitional cell) >90%: Smoking Occupational – rubber, dyes Cyclophosphamide Risk factors for squamous cell carcinoma: Schistosomiasis Smoking Presentation: Haematuria – usually painless, macroscopic
131
2ww referral for bladder cancer
Over 45 with unexplained visible haematuria, without UTI or persisting after treatment for UTI Over 60 with microscopic haematuria plus dysuria or raised WCC
132
How is bladder cancer diagnosed and managed?
Investigation – cystoscopy and biopsy or TURBT Spread – pelvic MRI, distant disease CT scanning Management – superficial may be managed with TURBT, may need intravesical chemotherapy, surgery (radical cystectomy and ileal conduit) or radical radiotherapy
133
List the types of renal stones and their aetiology and features
Calcium oxalate – hypercalcaemia, high dietary oxalate, radio-opaque Cysteine – associated with homocysteinuria, radio-opaque Uric acid – hyperuricaemia due to diet, haematological disease, associated with gout, ileostomy, radioluscent Calcium phosphate – hypercalcaemia, renal tubular acidosis, high urinary pH, radio-opaque Struvite – formed of magnesium, ammonium, phosphate, associated with chronic infections, slightly radio-opaque
134
Describe the presentation of renal stones
Renal colic – intermittent, severe, pain radiating from loin to groin, associated with nausea and vomiting Haematuria Flank tenderness Reduced urine output Symptoms of infection if present
135
How are renal stones investigated and managed?
Diagnosis – CT KUB is gold-standard Management Analgesia - NSAID IV fluids <5mm – likely to pass spontaneously, within 4 weeks of symptom onset If >5mm or conservative management failed can use shockwave lithotripsy, uteroscopy, percutaneous nephrolithotomy to pass stone If obstruction due to stones + infection this I a surgical emergency – nephrostomy tube, ureteric catheter or stent Prevention: Calcium stones – increase fluid intake, low salt diet, thiazide diuretics Oxalate stones – cholestyramine, pyridoxine Uric acid – allopurinol, urinary alkalinisation e.g. oral bicarbonate
136
What causes non-gonococcal urethritis? How is it managed?
Urethritis where gonococcal bacteria not identified from swab Causes – Cause not found in 50% Chlamydia Mycoplasma genitalium E. Coli Trichomonas vaginalis Management – oral azithromycin or doxycycline
137
Describe the aetiology and presentation of post-streptococcal glomerulonephritis
Occurs following infection with group A strep (strep pyogenes), usually tonsillitis Caused by immune complex deposition in glomeruli Usually young children Visible haematuria Proteinuria, leading to oedema Hypertension Oliguria Raised anti-streptolysin O titre Low C3
138
Describe the histological features of membraneous glomerulonephritis. How is membraneous glomerulonephritis managed? Describe the prognosis.
Histology – IgG and complement deposits on basement membrane ACEi or ARB – reduce proteinuria and improve prognosis Immunosuppression – only in severe or progressive disease, most spontaneously resolve 1/3 – spontaneous remission 1/3 – remain proteinuric 1/3 – develop ESRF
139
Describe the aetiology and presentation of Goodpasture’s syndrome
Anti-GBM antibodies attack glomerulus and pulmonary basement membranes Causes glomerulonephritis and pulmonary haemorrhage – AKI and haemoptysis classically
140
Describe the aetiology and histological appearance of rapidly progressive glomerulonephritis
Rapid loss of renal function Cause – secondary to Goodpasture’s syndrome, Wegner’s granulomatosis, SLE Red cell casts in urine Histology - crescenteric glomerulonephritis
141
Describe the causes of oliguria
Pre-renal: Hypovolaemia Cardiac disease – MI, PE, cardiac tamponade, congestive heart failure Vascular – renal artery stenosis, thrombosis Renal: Vasculitis, glomerulonephritis, acute tubular necrosis Post-renal: Obstruction – upper or lower tract obstruction (ureteral stricture, stone, BPH, tumours)
142
Describe the aetiology and presentation of epididymo-orchitis
Young men – STIs e.g. gonorrhoea, chlamydia Older men – E. Coli, enterococcus, klebsiella Mumps Presentation: Dysuria Urethral discharge - purulent Unilateral testicular swelling, erythema, pain Prehn’s sign – testicular pain better on elevating scrotum Tenderness especially over epididymis Systemically unwell – fever
143
How is epididymo-orchitis diagnosed and managed?
Urine C+S NAAT for chlamydia/gonorrhoea Charcoal swab of urethra discharge for gonorrhoea C+S If suspect mumps – saliva swab for PCR, serum antibodies US to rule out torsion/tumours Management If STI most likely – one off ceftriaxone IM plus doxycycline for 10-14 days If enteric most likely – send MSU, empirically treat with quinolone (ofloxacin or levofloxacin) or co-amoxiclav if quinolone contraindicated
144
Describe diagnosis of HIV
Screen those with risk factors (based on sexual history, travel history, IV drug use etc.) or presenting with other STI Test those with symptoms suggestive of seroconversion or AIDS-defining illnesses Verbal consent only needed for testing HIV antibodies and p24 antigen combined test Antibodies will develop at 4-6 weeks post-infection, 99% do by 3 months P24 antigen usually positive from 1-4 weeks after infection (earlier than antibody) If asymptomatic potentially exposed test at 4 weeks post-exposure Repeat testing at 3 months post-exposure if initially negative If symptomatic test now Can then test HIV RNA levels for viral load, CD4 count
145
Describe the prophylaxis available to reduce risk of HIV infection
PreP – pre-exposure prophylaxis For those at high risk (including MSM, transgender people who have sex with men, HIV-negative partners of HIV-postivie people with detectable/unknown viral load), combination of emtricitabine and tenofovir taken daily Post-exposure prophylaxis – given dependent on risk Combination of antiretrovirals (e.g. Tenofovir, emtricitabine) as soon as possible, up to 72 hours post-exposure, for 4 weeks Reduced risk of transmission by 80% Taken up to 72 hours post-exposure
146
List the most common causes of erectile dysfunction
Psychogenic – most common, especially in younger men (still have morning erections/spontaneous erections, history mental illness e.g. anxiety, new partner etc.) Vascular disease – hypertension, atherosclerosis, hyperlipidaemia, smoking Neurological disease - Parkinson’s, MS, stroke, spinal cord injury, peripheral neuropathy Hormonal – hypogonadism, hyperprolactinaemia, thyroid disease, Cushing’s Systemic disease – diabetes, renal failure Structural – Peyronie’s, penile/pelvic trauma Drugs – anti-psychotics, anti-depressants, anti-convulsants, antihypertensives, beta-blockers, diuretics, recreational drugs (Frequently multi-factorial)
147
Describe the assessment and management of erectile dysfunction and contraindications to management
Tests to rule out organic causes – FBC, LFTs, U&Es, lipids, HbA1c, TFTs, serum total testosterone, serum prolactin Modify risk factors – diet, smoking, diabetic control, alcohol intake Psychosexual counselling PDE-5 inhibitors (sildenafil, vardenafil) – take on an empty stomach 30 minutes before intercourse, can last 4 hours (if lasts longer seek medical attention) Contraindications – concurrent nitrate use, cardiovascular or cerebrovascular disease in previous 6 months (including hypo/hypertension) Side effects – headache, flushing, dizziness Penile prosthesis – inflatable implants, semirigid rods
148
Describe the aetiology, presentation and management of a hydrocoele
Communicating – usually in newborns, patency of processus vaginalis which allows peritoneal fluid to leak into scrotum Non-communicating – excessive fluid production within tunica vaginalis Presentation – unilateral scrotal swelling, fluctuant, painless, transilluminates Confined to scrotum, can ‘get above’ it Can develop secondary to epididymo-orchitis, testicular torsion, testicular tumours Usually conservative management, should US to exclude underlying cause e.g. tumour
149
Describe the types of testicular tumours and their epidemiology
Pre-pubertal – yolk-sac, teratoma Older – lymphoma, seminomas Risk factors – cryptorchidism, infertility, Klinefelter’s, mumps orchitis, FHx
150
Describe the presentation, assessment, and management of testicular tumours
Presentation: Testicular lump – hard, irregular, usually painless, does not transilluminate Testicular pain Hydrocele Torsion Gynaecomastia – Sertoli cell (oestrogen producing) Assessment: Testicular US Tumour markers AFP – non-seminoma BhCG – germ cell tumours (seminoma and non-seminoma) LDH – general malignancy marker Staging - CT Royal Marsden staging – local spread, LN above and below diaphragm, distant mets (LN, lungs, liver, brain) Management: Radical orchidectomy Chemotherapy Radiotherapy Fertility management – sperm banking
151
Describe the aetiology and presentation of benign prostatic hyperplasia
Older men Hyperplasia of stromal and epithelial cells of prostate Presentation: Hesitancy Urgency Frequency Straining to pass urine Dribbling Incomplete voiding Poor stream Nocturia UTIs Urinary retention – oliguria/anuria, painful then painless, suprapubic distension
152
How is benign prostatic hypertrophy assessed and managed?
Investigations – PR exam, urine dip for infection PSA – if there is obstructive symptoms or if patient preference (unreliable) Management: 1st line - alpha-1 agonists (tamsulosin, alfuzosin) Decrease smooth muscle tone of bladder and prostate Adverse effects – dizziness, postural hypotension, dry mouth, depression 2nd line – 5 alpha-reductase inhibitors e.g. finasteride Block conversion of testosterone to dihydrotestosterone If patient has significantly enlarged prostate, high risk of progression May take 6 months to work, reduce volume of prostate Adverse effects – erectile dysfunction, reduced libido, ejaculation problems, gynaecomastia Combination therapy (alpha-1 agonist and 5-alpha reductase inhibitor) if moderate/severe symptoms Can add antimuscarinic e.g. tolterodine if storage + voiding symptoms Surgery – transurethral resection of prostate (TURP), transurethral electrovaporisation of prostate (TEVAP), holmium laser enucleation of the prostate (HoLEP)
153
How is acute urinary retention managed?
Confirm with bladder US - >300cc Insert urinary catheter, measure volume drained in 15 minutes (>400 confirms acute retention) Post-obstructive diuresis – IVF and correct electrolytes
154
Describe the aetiology and presentation of prostate cancer
Most are adenocarcinoma, in peripheral zone, testosterone dependent Often asymptomatic Lower urinary symptoms of obstruction: Frequency Urgency Hesitancy Dribbling Poor stream Nocturia Other symptoms Haematuria, haematospermia Erectile dysfunction Back, perineal or testicular pain PR exam – asymmetrical, hard, nodular enlargement, loss of median sulcus
155
Describe diagnosis and management of prostate cancer
Diagnosis: PSA – unreliable marker Can also be raised in BPH, UTIs, prostatitis, exercise (cycling), recent ejaculation or prostate stimulation PR exam First-line examination – multiparametric MRI of the prostate Prostate biopsy to diagnose – transrectal or transperineal Isotope bone scan to check for bony mets Use Gleason grading system and TNM for staging Management: Surveillance or watchful waiting if early/low grade External beam radiotherapy Brachytherapy Hormone therapy – androgen receptor blockers, GnRH agonists (goserelin), bilateral orchidectomy (rare) Chemotherapy - docetaxel Surgery – radical prostatectomy
156
Describe the aetiology, presentation and clinical consequences of polycystic kidney disease
Genetic – autosomal dominant (more common) and autosomal recessive ADPKD – mostly chromosome 16, 15% chromosome 4 ARPKD – chromosome 6 Causes formation of multiple cysts on the kidneys, also associated with cerebral berry aneurysms, hepatic/splenic/pancreatic/ovarian and prostatic cysts, mitral regurgitation, colonic diverticula, aortic root dilatation Presentation: Family history Bulky kidneys on examination Incidental finding on imaging Cyst rupture – haematuria Hypertension/cardiovascular disease Renal impairment – ESRF by 40s/50s in ADPKD, childhood in ARPKD Loin pain Renal stones more common
157
Describe diagnosis and management of polycystic kidney disease
Diagnosis ARPKD – often antenatal due to oligohydramnios US – cysts on kidneys Genetic testing Management ADPKD – tolvaptan (vasopressin receptor 2 antagonist), slows cyst development and renal failure RRT
158
List options for renal replacement therapy
Haemodialysis – via AV fistula or central venous catheter (tunnelled or non-tunnelled) Peritoneal dialysis – continuous ambulatory or automated Renal transplant
159
List potential complications of renal replacement therapy
Haemodialysis: Thrombophlebitis Steal syndrome Thrombosis Line infection, sepsis Hypertension Peritoneal dialysis: Spontaneous bacterial peritonitis Peritoneal fibrosis – failure Fluid retention Hyperglycaemia Renal transplant: Acute rejection Chronic rejection Complications of immunosuppression – opportunistic infections, cancers (lymphoma, skin cancer) Recurrence of original disease DVT/PE
160
Describe the aetiology and presentation of gastro-oesophageal reflux disease
Risk factors: H. Pylori infection Excess alcohol consumption Smoking Obesity Pregnancy NSAIDs Presentation – burning pain in chest/epigastrum, worse lying down or after meals, waterbrash, chronic dry cough, acidic taste in mouth, bloating
161
How is gastro-oesophageal reflux disease assessed and managed?
Endoscopy if: >55 Symptoms >4 or persistent despite treatment Dysphagia Weight loss Gold-standard for diagnosis – 24-hour oesophageal pH monitoring Testing for H Pylori – carbon-13 urea breath test, stool antigen test, rapid urease test during endoscopy Management: Lifestyle advice Antacids e.g. gaviscon Proton pump inhibitor – omeprazole, lansoprazole H2 receptor antagonists – ranitidine H. Pylori eradication – PPI plus amoxicillin + clarithromycin or metronidazole, for 7 days
162
Describe management of peptic ulcer disease
Uncomplicated: PPI +/- H. Pylori eradication if test positive Acute bleeding: A-E assessment IV PPI Endoscopic intervention – adrenaline injection, cauterisation If endoscopic intervention fails – IR with arterial embolisation, surgery Perforation: A-E assessment Erect CXR to look for pneumoperitoneum Emergency surgery
163
Describe the aetiology and presentation oesophageal varices
Liver disease (cirrhosis) causes increased vascular resistance through liver, leading to portal vein hypertension, causes enlargement of veins including oesophageal Combined with liver disease-associated coagulopathy Presentation: Asymptomatic until bleed Cause melaena and/or haematemesis
164
Describe the management of oesophageal varices
Prophylaxis: Propranolol Endoscopic variceal band ligation Transjugular intrahepatic portosystemic shunt (TIPSS) Acute bleed: A-E assessment Fluid resuscitation, blood transfusion Correct clotting Terlipressin (or octreotide 2nd line) Prophylactic IV antibiotics - co-amoxiclav Stop anticoagulants Then endoscopy – variceal band ligation or sclerotherapy Sengstaken-Blakemore tube if uncontrolled haemorrhage TIPSS if recurrent/problematic bleeding
165
Describe the aetiology, presentation, clinical consequences, prevention and treatment of viral hepatitis
Hepatitis A – Transmitted via faecal oral route – infected water or food Presentation – nausea, vomiting, anorexia, jaundice, cholestasis Resolves without treatment in 1-3 months, complications rare Vaccination available – 2 doses, 6-12 months apart, give to high risk and before travel to high prevalence areas Hepatitis E – Transmitted via faecal oral route – infected water or food Causes mild illness, cleared in 1 month Rarely can cause liver failure, more in immunocompromised and pregnant No vaccine Hepatitis D – Transmitted via blood/bodily fluids, only infects those with hepatitis B If superinfection (hepatitis B positive then becomes infected with hepatitis D) high risk fulminant hepatitis, chronic hepatitis, cirrhosis No vaccine Hepatitis B – Transmitted via blood/bodily fluids, can be vertical transmission during birth Causes fever, jaundice, transaminitis Complications – chronic hepatitis, fulminant liver failure, HCC Vaccination – children, at risk (healthcare, IVDU, sex workers), 10-15% don’t respond Management – pegylated interferon-alpha is only treatment, reduces viral replication (may also use anti-virals e.g. tenofovir) In pregnancy – babies of mothers who are hepatitis B positive receive vaccination and immunoglobulin after birth, no risk of transmission with breastfeeding Hepatitis C – Transmitted via blood/bodily fluids, can have vertical transmission Clinical features – transient transaminitis/jaundice, fatigue, arthralgia Majority develop chronic hepatitis C, associated with arthritis, Sjogren’s, cirrhosis, HCC, glomerulonephritis Anti-viral treatments can cure in >90%
166
List signs, investigation findings and potential complications of cirrhosis
Signs: Jaundice Hepatomegaly (can shrink later) Splenomegaly Spider naevi Palmar erythema Gynaecomastia and testicular atrophy Bruising Ascites Caput medusae Asterixis Investigation results: Decompensated – ALT, AST, ALP, bilirubin deranged Low albumin PT increased Hyponatraemia due to fluid retention Hepatorenal syndrome – U&Es deranged AFP monitor HCC Complications: Malnutrition Portal hypertension, varices, variceal bleeding Ascites and spontaneous bacterial peritonitis Hepato-renal syndrome Hepatic encephalopathy
167
Describe management of cirrhosis and its complications
Monitor for HCC – US and AFP every 6 months High protein, low sodium diet MELD score every 6 months Consider liver transplant Malnutrition – regular meals, low sodium, high protein/calorie, avoid alcohol Portal hypertension/varices – propranolol, elastic band ligation, TIPS, acute management if bleeding Ascites – fluid/sodium restriction, prophylactic antibiotics for SBP (if <15g/L protein in ascitic fluid), spironolactone, paracentesis (tap or drain), TIPS SBP – ascitic culture, IV antibiotics (co-trimoxazole) Hepatorenal syndrome – terlipressin, HAS, TIPS, liver transplant Hepatic encephalopathy – laxatives (lactulose), antibiotics, nutritional support
168
Describe the scoring systems used in liver cirrhosis
Childs-Pugh score – grade severity and give prognosis Uses bilirubin, albumin, INR, ascites, encephalopathy MELD (model for end-stage liver disease) – predicts 3-month mortality Uses bilirubin, creatinine, INR, sodium, whether they need dialysis or not
169
Describe the genetic basis of Huntington’s disease
Autosomal dominant, displays genetic anticipation (successive generations have earlier age of onset and more severe disease) Trinucleotide repeat of HTT gene on chromosome 4
170
Describe the management of alcohol withdrawal
Assess risk – Glasgow modified alcohol withdrawal scale Assess for risk of Wernicke’s encephalopathy Benzodiazepines (oral diazepam if able to tolerate, severe may need IV) – fixed dose or treatment triggered depending on risk Wernicke’s or high risk for Wernicke’s – initially IV Pabrinex then oral thiamine, measure and replace magnesium as required
171
Describe presentation of inflammatory bowel disease and compare histological features in Crohn’s and UC
Presentation: Crohn’s – usually non-bloody diarrhoea, weight loss, perianal disease, oral ulcers, palpable abdominal mass in RIF, stricture formation leading to bowel obstruction, fistulae Ulcerative colitis – bloody diarrhoea, LIF pain, tenesmus, strongly associated with PSC and uveitis, higher risk toxic megacolon and colorectal cancer Histological features Crohn’s – terminal ileum most commonly affected, transmural inflammation, skip lesions, cobblestone mucosa, goblet cells, granulomas, strictures, fistulae UC – only colon and rectum affected, mucosal inflammation only, continuous inflammation, inflammatory infiltrate in lamina propria, crypt abscesses
172
How is inflammatory bowel disease diagnosed?
FBC – anaemia Inflammatory markers – CRP, ESR U&Es – dehydration, electrolyte disturbance LFTs – albumin may be low in protein losing enteropathy Serum ferritin, B12, folate and vitamin D – deficiencies due to malabsorption Coeliac serology to exclude coeliac Stool C+S to exclude infective gastroenteritis Faecal calprotectin – if high suggests active inflammation Diagnosis – endoscopy (OGD, colonoscopy, flexible sigmoidoscopy) AVOID COLONOSCOPY IF RISK OF PERFORATION Imaging – CT, MRI, barium enema
173
List common extra-intestinal features of IBD
Erythema nodosum – tender, red bumps Arthritis Episcleritis – more common in Crohn’s Uveitis – more common in UC Pyoderma gangrenosum – ulcers Primary sclerosing cholangitis – more common in UC
174
Describe management of Crohn’s disease
Important to stop smoking – makes Crohn’s worse! Inducing remission: 1st line = Steroids (oral, topical or IV) +/- immunosuppressants e.g., azathioprine (or methotrexate), mercaptopurine 2nd line = 5-ASA drugs e.g. mesalazine Isolated peri-anal disease – metronidazole Refractory/fistulating disease – infliximab (+ azathioprine or methotrexate) Maintaining remission: 1st line – azathioprine or mercaptopurine (check TPMT activity before starting) Others – methotrexate, infliximab, adalimumab Surgery – very commonly needed Stricturing terminal ileal disease – ileocaecal resection Stricturoplasty Perianal disease – laying open fistulae or seton placement, abscess incision and drainage
175
Describe management of ulcerative colitis
Inducing remission (mild to moderate): 1st line – topical/oral salicylates e.g., mesalazine 2nd line – steroids Inducing remission (severe): 1st line – IV steroids 2nd line – IV ciclosporin Maintaining remission: Aminosalicylates e.g., mesalazine oral or rectal Azathioprine Mercaptopurine Surgery – panproctocolectomy is curative, create ileostomy or ileo-anal anastomosis (J-pouch)
176
How are UC flares graded in terms of severity?
Truelove and Witt Mild - less than 4 stools daily, no/little blood, apyrexial, normal ESR/CRP, HR less than 70, Hb more than 110 Moderate – 4-6 stools per day, moderate blood, low-grade fever, mildly elevated ESR/CRP, HR 70-90, Hb 105-110 Severe - more than 6 stools per day, high fever, lots of blood, high ESR/CRP, Hb less than 105, HR over 90
177
Describe the aetiology of acute pancreatitis
Most common – alcohol excess, biliary obstruction e.g., gallstones Others: Autoimmune pancreatitis – SLE, Sjogren’s Hyperlipidaemia Hypercalcaemia Drugs – 5-ASAs, steroids, NSAIDs, diuretics Mumps ERCP
178
Describe the clinical presentation and diagnosis of acute pancreatitis
Presentation: Epigastric pain, radiating to back Worse after eating Nausea and vomiting Systemically unwell Epigastric tenderness Grey-Turner’s sign and Cullen’s sign – haemorrhagic pancreatitis (rare) Investigations: Raised amylase, >3x upper limit Lipase – more sensitive than specific, longer half-life so good for delayed presentations US to determine aetiology (look for biliary obstruction) CT for complications – necrosis. Pseudocysts Scoring systems e.g. Glasgow Score
179
How is acute pancreatitis managed?
Supportive management: IVF Analgesia Anti-emetics NBM Treat cause e.g., gallstones (ERCP) Treat complications – drainage of collections etc.
180
Describe the aetiology and clinical presentation of chronic pancreatitis
Aetiology – mostly alcohol, also genetic (CF, haemochromatosis), ductal obstruction (tumours, stones) Pain – worse following meal Exocrine dysfunction – steatorrhoea Endocrine dysfunction – diabetes mellitus
181
Describe diagnosis and management of chronic pancreatitis
CT shows calcification Faecal elastase to assess exocrine function Alcohol abstinence Analgesia – difficult to manage pain Creon Insulin ERCP with stenting for strictures, stones Surgical intervention
182
What is the differential diagnosis for jaundice?
Pre-hepatic – excess RBC breakdown Unconjugated hyperbilirubinaemia Haemolytic anaemia Gilbert’s syndrome Intra-hepatic – hepatic cell dysfunction Unconjugated and conjugated hyperbilirubinaemia Alcoholic liver disease Viral/autoimmune hepatitis Haemochromatosis PBC or PSC HCC Post-hepatic – obstruction of biliary drainage Conjugated hyperbilirubinaemia Gallstones Cholangiocarcinoma, strictures, drug-induced cholestasis Pancreatic cancer Abdominal masses
183
How to interpret LFTs
AST:ALT >2 – acute alcoholic hepatitis, cirrhosis AST:ALT around 1 – viral hepatitis ALT>AST – chronic liver disease Isolated raised bilirubin with jaundice – suggests pre-hepatic cause e.g. Gilbert’s, haemolysis Albumin – measure of liver synthetic function, can be low in liver disease, acute phase response, enteropathy or nephrotic syndrome AST and ALT – markers of hepatocellular injury ALP – raised in biliary obstruction (also in bone disease, pregnancy, malignancy) GGT – biliary obstruction, alcohol, drugs e.g., phenytoin
184
Describe the aetiology and presentation of gallstones and the complications of gallstones
Risk factors – female, middle aged, obese, hyperlipidaemia, haemolysis Presentation: Asymptomatic if uncomplicated Biliary colic – Sudden onset severe RUQ/epigastric pain, lasting 30 minutes – hours then subsiding Associated nausea, vomiting, sweating Associated with eating Acute cholecystitis – Persistent RUQ pain which is sharper and more localised, exacerbated by movement, radiating to right shoulder Systemically unwell with vomiting and fever Positive Murphy’s sign (painful inspiratory catch during RUQ palpation – pain on inspiration when palpating gallbladder) May have palpable RUQ mass Ascending cholangitis – Charcot’s triad – RUQ pain, fever and jaundice Hypotension Confusion Raised inflammatory markers
185
Describe the diagnosis and management of biliary disease
First-line investigation – US of the biliary tree MRCP then used for further investigation or if US is negative but high clinical suspicion ERCP – used for imaging, sphincterotomy of sphincter of Oddi, clear stones, insert stents, take biopsies if tumour suspected Complications – bleeding, cholangitis, pancreatitis Asymptomatic gallstones – may be used conservatively, lifestyle advice Biliary colic – analgesia, elective laparoscopic cholecystectomy (emergency if severe pain or multiple attacks) Acute cholecystitis – antibiotics, emergency laparoscopic cholecystectomy Ascending cholangitis – IV fluids, IV antibiotics, urgent decompression of biliary system with ERCP, cholecystectomy when well enough CBD stone causing obstructive jaundice – IV fluids, anti-itch medications, ERCP or emergency laparoscopic cholecystectomy with CBD exploration
186
Describe the presentation of peripheral arterial disease
Intermittent claudication – cramping pain in legs/buttocks due to ischaemia, initially with exertion (predictable walking distance) then rest pain in critical limb ischaemia Pain at night, relieved by standing/putting feet on floor Cold extremities Sensation loss Ulcers – arterial (punched out, deep, painful, on sites of trauma such as heels) or venous (sloughy, irregular edges, shallow, around gaiter areas, usually medial malleolus, painless) Prolonged CRT Positive Buerger’s test
187
How is peripheral vascular disease diagnosed and managed?
Ankle-Brachial pressure index: 0.9-1.3 normal 0.6-0.9 mild disease 0.3-0.6 moderate to severe Less than 0.3 severe to critical ischaemia >1.3 suggests calcification Doppler US scan then CT angiography Management Chronic – lifestyle advice, statin, anticoagulation (clopidogrel), diabetic control Surgery – angioplasty, bypass grafting Acute limb ischaemia – Conservative – prolonged course of heparin Surgical – embolectomy, intra-arterial thrombolysis, bypass surgery, angioplasty Irreversible limb ischaemia – urgent amputation
188
Describe the presentation of acute limb ischaemia
Pain Pallor Pulselessness Paraesthesia Perishingly cold Paralysis
189
What are the potential complications of acute limb ischaemia?
Irreversible limb ischaemia requiring amputation 20% mortality rate Reperfusion injury – compartment syndrome, AKI (due to hyperkalaemia, acidosis, myoglobinaemia)
190
Describe the aetiology, presentation, diagnosis and management of melanoma
Main risk factor is UVB exposure Genetic mutations e.g. BRAF Presentation – new naevus or change to existing Asymmetry, irregular, uneven colour, diameter >6mm, evolving Advanced – bleeding, ulceration, lymph node involvement Diagnosis – excision biopsy, sentinel LN biopsy or FNA if clinically suspicious LNs Staging – CT CAP TNM staging Breslow thickness Management Wide local excision +/- lymphadenectomy Metastatic disease common, options for management: Ipilimumab – CTLA4 inhibitor Pembrolizumab and nivolumab – PD1 inhibitors
191
List common drugs which cause skin reactions and describe these reactions
Amoxicillin – rash with infectious mononucleosis Doxycycline – photosensitivity Trimethoprim – rashes, photosensitivity, pruritus CCB – flushing Steroids – acne Any drug – allergic rash Stevens-Johnson syndrome – penicillins, sulphonamides, anti-epileptics, allopurinol, NSAIDs, OCP
192
Describe the presentation and types of psoriasis
Types: Plaque psoriasis – most common, extensor surfaces and scalp Flexural psoriasis – smooth, on flexural surfaces Guttate psoriasis – triggered by strep infection, multiple red, teardrop lesions Pustular psoriasis – on palms and soles, can be systemically unwell Erythrodermic psoriasis – extensive erythematous inflamed areas, medical emergency Salmon-pink, raised, scaly, itchy, well-demarcated lesions Usually on extensor surfaces, scalp, symmetrical distrubition Auspitz phenomenon – pin-prick bleeding with trauma Koebner phenomenon – development of plaque on areas of trauma Nail changes – pitting, onycholysis, subungal hyperkeratosis
193
How is psoriasis managed?
Emollients + 1st line – potent corticosteroid applied once daily plus vitamin D analogue once daily 2nd line – vitamin D twice daily 3rd line – potent corticosteroid applied twice daily or a coal tar preparation once or twice daily Can also use short-acting dithranol Phototherapy – narrowband UVB Systemic therapy 1st line - oral methotrexate Ciclosporin Biologic agents – infliximab, etanercept, adalimumab
194
How is acne vulgaris managed?
Step-up regimen 1. Single topical therapy – topical retinoids, benzoyl peroxide 2. Topical combination therapy – topical antibiotic, benzoyl peroxide, topical retinoid 3. Oral antibiotics – tetracyclines (e.g., doxycycline) + topical retinoid or benzoyl peroxide 4. COCP alternative to oral antibiotics in women 5. Oral isotretinoin Side effects of isotretinoin – Teratogenicity – two forms of contraception in women of childbearing age Dry skin, eyes, mouth, lips – most common Low mood Raised triglycerides Intracranial hypertension Photosensitivity
195
Describe the presentation and management of rosacea
Presentation: Nose, cheeks, forehead Flushing Telangiectasia Papules and pustules Blepharitis Sunlight exacerbates Management Suncream Erythema/flushing – topical brimonidine (alpha-adrenergic agonist) Papules and/or pustules – topical ivermectin +/- doxycycline
196
Describe the presentation of skin squamous cell carcinomas and their precancerous forms
Can be nodular, indurated or keratinised with associated ulceration or bleeding On sun-exposed areas Precancerous lesions: Bowen's disease or actinic keratosis - slow-growing, small, red, scaly lesion
197
How is SCC diagnosed and managed?
Diagnosis – biopsy If suspicion of LN involvement – imaging +/- FNA of suspicious nodes Management Surgical – excision biopsy If close margins – wide local excision, Mohs micrographic surgery, adjuvant radiotherapy If small, low risk – curettage and cautery only
198
How are precancerous skin lesions managed?
Avoid further damage – sunscreen etc. Fluorouracil cream – causes skin irritation, may need topical steroid Topical diclofenac – fewer side effects, moderate efficacy Topical imiquimod Cryotherapy Curettage and cautery
199
Describe the presentation, diagnosis, and management of basal cell carcinomas
Presentation – on sun-exposed areas, small slow-growing lesions, raised pearly edges, telangiectasia, pain, bleeding, ulceration Subtypes – nodular (most common), superficial, Morphoeic, basosquamous Diagnosis – excision biopsy Management Cryotherapy Curretage and electrodissection (small lesions) Immune response modulator – topical imiquimod (superficial) Topical chemotherapy – 5-fluorouracil (superficial) Radiotherapy – older patients Surgical – excision biopsy +/- free flap or skin graft Mohs’ micrographic
200
Describe the criteria for diagnosis of type 2 diabetes
HbA1c >48 Fasting glucose >7 Random glucose >11 OGTT 2 hour >11
201
Describe the strategy for management of type 2 diabetes
Diagnosis of T2DM – give lifestyle advice, start metformin (give modified release if don’t tolerate), assess CV risk (QRISK), if high risk (QRISK >10%) or established CV disease start SGLT2 inhibitor when stable on metformin, if low risk don’t start SGLT2 inhibitor (At any time if CV risk changes, become high risk start SGLT2) Initial HbA1c target is <48 If >48 start second drug from sulfonylurea, DPP-4 inhibitor, or pioglitazone After second drug added HbA1c target is <53 If >53 add another drug from above or start insulin If >53 swap one drug for GLP-1 inhibitor if BMI >35 or occupational contraindication to insulin (only continue if reduction in HbA1c of at least 11 and 3% weight reduction in 6 months) Measure HbA1c every 3-6 months
202
Describe the mechanism of action, side effects and contraindications of metformin
Biguanide MOA – increases sensitivity to insulin and decreases gluconeogenesis Side effects – GI upset, lactic acidosis Contraindications – renal failure (review use if eGFR less than 45, discontinue if eGFR less than 30), conditions predisposing to lactic acidosis (recent MI, sepsis, AKI, severe dehydration) Titrate dose slowly to minimise GI upset Weight neutral Low risk hypoglycaemia
203
Describe the mechanism of action and side effects of SGLT2 inhibitors and give examples
-gliflozins e.g., dapagliflozin, empagliflozin, canagliflozin Inhibit SGLT2 which reabsorbs glucose in PCT, leads to increased glucose secretion in urine Side effects – UTIs, normoglycaemic acidosis, canagliflozin has been shown to increase risk of lower-limb amputation Weight loss Low risk hypoglycaemia
204
Describe the mechanism of action and side effects of pioglitazone
Thiazolidinedione MOA – increases insulin sensitivity, decreases gluconeogenesis Side effects – fluid retention, anaemia, heart failure, increase risk bladder cancer Weight gain Low risk hypoglycaemia
205
Describe the mechanism of action and side effects of DPP-4 inhibitors and give examples
-gliptins e.g., sitagliptin, linagliptin, saxaglitpin Inhibit DPP-4 to increase GLP-1 – increases insulin secretion, inhibits glucagon production, slows GI absorption Side effects – GI upset, URTI symptoms, pancreatitis Weight neutral Low risk hypoglycaemia
206
Describe the mechanism of action and side effects of GLP-1 mimetics and give examples
-tide e.g. liraglutide, exenatide Increase insulin secretion, inhibit glucagon production, slow GI absorption Side effects – GI upset, dizziness Weight loss Low risk hypoglycaemia Subcutaneous administration
207
Describe the mechanism of action and side effects of sulfonylureas and give examples
Gliclazide Increase insulin secretion Side effects – increased risk CVD Weight gain Hypoglycaemia risk
208
Describe the advantages and disadvantages of insulin-therapy in management of type 2 diabetes
Risk of hypoglycaemia Causes weight gain Subcutaneous administration
209
What is Zieve syndrome?
Coombs negative haemolysis, cholestatic jaundice, transient hyperlipidaemia associated with heavy alcohol use, typically following a binge